This site is intended for Healthcare Professionals only.

Tag: denosumab

spot_imgspot_img

MHRA approves first drug via the new IRP in 30 days

XGEVA is the first product to be authorised by the regulator through the new International Recognition Procedure (IRP). The latest formulation of XGEVA (denosumab)...